Need and value of targeted immunosuppressive therapy in giant cell arteritis

Despite the heterogeneity of the giant cell arteritis (GCA) at the level of clinical manifestations and the cellular and molecular players involved in its pathogenesis, GCA is still treated with standardised regimens largely based on glucocorticoids (GC). Long-term use of high dosages of GC as requi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandovici, Maria, van der Geest, Kornelis S M, van Sleen, Yannick, Brouwer, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Vasculitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845325/
https://www.ncbi.nlm.nih.gov/pubmed/35149602
http://dx.doi.org/10.1136/rmdopen-2021-001652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845325/
https://www.ncbi.nlm.nih.gov/pubmed/35149602
http://dx.doi.org/10.1136/rmdopen-2021-001652

Ejemplares similares